GENERATE:BIOMEDICINES Trademark

Trademark Overview


On Monday, December 11, 2023, a trademark application was filed for GENERATE:BIOMEDICINES with the United States Patent and Trademark Office. The USPTO has given the GENERATE:BIOMEDICINES trademark a serial number of 98308316. The federal status of this trademark filing is SUSPENSION LETTER - MAILED as of Friday, July 5, 2024. This trademark is owned by Generate Biomedicines, Inc.. The GENERATE:BIOMEDICINES trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research, development, and design of pharmaceuticals and medicines for others; scientific research in the field of pharmaceutical and medicine design, discovery and development services for others; research and development of technology for others in the field of pharmaceuticals; research and development of technology for others in the field of computational biology; pharmaceutical, medical, scientific, biotechnology, and biopharmaceutical research and development for others; collecting and analyzing complex biological data through the use of artificial intelligence, namely, data automation and collection service using proprietary software to evaluate, analyze and collect biological data; computer assisted molecule design involving the use of artificial intelligence technology, namely, product design and development in the field of medicine; conducting scientific and pharmaceutical artificial intelligence research services for others to identify molecules and compounds for drug develop...
generate:biomedicines

General Information


Serial Number98308316
Word MarkGENERATE:BIOMEDICINES
Filing DateMonday, December 11, 2023
Status653 - SUSPENSION LETTER - MAILED
Status DateFriday, July 5, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesResearch, development, and design of pharmaceuticals and medicines for others; scientific research in the field of pharmaceutical and medicine design, discovery and development services for others; research and development of technology for others in the field of pharmaceuticals; research and development of technology for others in the field of computational biology; pharmaceutical, medical, scientific, biotechnology, and biopharmaceutical research and development for others; collecting and analyzing complex biological data through the use of artificial intelligence, namely, data automation and collection service using proprietary software to evaluate, analyze and collect biological data; computer assisted molecule design involving the use of artificial intelligence technology, namely, product design and development in the field of medicine; conducting scientific and pharmaceutical artificial intelligence research services for others to identify molecules and compounds for drug development, namely, scientific research in the field of pharmaceuticals

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, December 11, 2023
Primary Code042
First Use Anywhere DateTuesday, December 21, 2021
First Use In Commerce DateTuesday, December 21, 2021

Trademark Owner History


Party NameGenerate Biomedicines, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Trademark Events


Event DateEvent Description
Tuesday, March 12, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, December 11, 2023NEW APPLICATION ENTERED
Monday, April 8, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 3, 2024ASSIGNED TO EXAMINER
Monday, April 8, 2024NON-FINAL ACTION WRITTEN
Monday, April 8, 2024NON-FINAL ACTION E-MAILED
Wednesday, July 3, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, July 3, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, July 3, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, July 5, 2024NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, July 5, 2024LETTER OF SUSPENSION E-MAILED
Friday, July 5, 2024SUSPENSION LETTER WRITTEN